biomedicale

Focalis (MO)

FOCALIS is an innovative startup that develops, produces, and markets medical devices for septic and/or aseptic prosthetic revision procedures. The activity concentrates on integration of existing technologies with new, original solutions capable of rendering surgical operations safer, more effective, and less invasive.

The FOCALIS approach aims to reduce the need for replacing prostheses and the risk of relapse, in response to a real need in the orthopaedic sector.

BONEARMED (BO)

BoneArmed was founded in 2023 in Bologna, operating in the orthopaedic biomedical sector. The startup produces and markets an implantable medical device for treating knee arthritis, applying a completely innovative approach from the perspectives of both cause of arthritic pain and the implanting of the device.

Cellply (BO)

Cellply is a biotechnology company that develops scientific tools automating cell-based functional assays whose aim is to deeply characterize the mode of action of both approved and novel anti-cancer drugs, being able to evaluate the heterogeneity in function of both immune and tumor cells with a single-cell resolution.